Glaukos (GKOS) EBITDA Margin (2016 - 2025)
Glaukos (GKOS) has disclosed EBITDA Margin for 12 consecutive years, with 13.41% as the latest value for Q4 2025.
- On a quarterly basis, EBITDA Margin rose 4058.0% to 13.41% in Q4 2025 year-over-year; TTM through Dec 2025 was 7.99%, a 2392.0% increase, with the full-year FY2025 number at 7.99%, up 2392.0% from a year prior.
- EBITDA Margin was 13.41% for Q4 2025 at Glaukos, up from 12.26% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 14.76% in Q3 2021 to a low of 50.57% in Q2 2022.
- A 5-year average of 22.9% and a median of 26.34% in 2024 define the central range for EBITDA Margin.
- Peak YoY movement for EBITDA Margin: skyrocketed 13134bps in 2021, then tumbled -5911bps in 2023.
- Glaukos' EBITDA Margin stood at 6.36% in 2021, then plummeted by -845bps to 47.36% in 2022, then increased by 1bps to 46.89% in 2023, then surged by 42bps to 27.17% in 2024, then skyrocketed by 149bps to 13.41% in 2025.
- Per Business Quant, the three most recent readings for GKOS's EBITDA Margin are 13.41% (Q4 2025), 12.26% (Q3 2025), and 18.28% (Q2 2025).